Difference between revisions of "Event:210"

From AOP-Wiki
Jump to: navigation, search
(Updated summary tables from widget page.)
(unknown event user updated summary tables from widget page.)
 
(3 intermediate revisions by the same user not shown)
Line 9: Line 9:
  
 
== Key Event Overview ==
 
== Key Event Overview ==
Please follow link to [http://ec2-23-21-255-223.compute-1.amazonaws.com/aopportal/events/{{PAGENAMEE}} widget page] to edit this section.
+
Please follow link to [//{{SERVERNAME}}/events/{{PAGENAMEE}} widget page] to edit this section.
 +
 
 +
<span style="color:#FF0000">'''If you manually enter text in this section, it will get automatically altered or deleted in subsequent edits using the widgets.'''</span>
  
 
=== AOPs Including This Key Event ===
 
=== AOPs Including This Key Event ===
Line 20: Line 22:
 
!Event Type
 
!Event Type
 
!Essentiality
 
!Essentiality
 
|-
 
 
|[[Aop:9|Binding of agonists to NMDAR can trigger neuroinflammation leading to neurodegeneration]]||KE||[[Aop:9#Essentiality of the Key Events|Strong]]
 
  
 
|-
 
|-
Line 55: Line 53:
  
 
|}
 
|}
 +
 
== How this Key Event works ==
 
== How this Key Event works ==
  

Latest revision as of 18:47, 15 February 2016



Event Title

Oxidative stress, N/A
Short name: Oxidative stress, N/A

Key Event Overview

Please follow link to widget page to edit this section.

If you manually enter text in this section, it will get automatically altered or deleted in subsequent edits using the widgets.

AOPs Including This Key Event

AOP Name Event Type Essentiality
Binding to SH/selen-proteins can trigger neuroinflammation leading to neurodegeneration KE Strong

Taxonomic Applicability

Name Scientific Name Evidence Links

Level of Biological Organization

Biological Organization

How this Key Event works

How it is Measured or Detected

Methods that have been previously reviewed and approved by a recognized authority should be included in the Overview section above. All other methods, including those well established in the published literature, should be described here. Consider the following criteria when describing each method: 1. Is the assay fit for purpose? 2. Is the assay directly or indirectly (i.e. a surrogate) related to a key event relevant to the final adverse effect in question? 3. Is the assay repeatable? 4. Is the assay reproducible?

Evidence Supporting Taxonomic Applicability

References